Literature DB >> 23507082

Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding.

Vijay R More1, Jialin Xu1, Prajakta C Shimpi1, Clyde Belgrave2, James P Luyendyk3, Masayuki Yamamoto4, Angela L Slitt5.   

Abstract

The nuclear factor E2-related factor 2 (Nrf2)-Kelch-like ECH-associated protein 1 (Keap1) pathway upregulates antioxidant and biotransformation enzyme expression to counter cellular oxidative stress. The contributions of Nrf2 to other cellular functions, such as lipid homeostasis, are emerging. This study was conducted to determine how enhanced Nrf2 activity influences the progression of metabolic syndrome with long-term high-fat diet (HFD) feeding. C57BL/6 and Keap1-knockdown (Keap1-KD) mice, which exhibit enhanced Nrf2 activity, were fed a HFD for 24 weeks. Keap1-KD mice had higher body weight and white adipose tissue mass compared to C57BL/6 mice on HFD, along with increased inflammation and lipogenic gene expression. HFD feeding increased hepatic steatosis and inflammation to a greater extent in Keap1-KD mice compared to C57BL/6 mice, which was associated with increased liver Cd36, fatty acid-binding protein 4, and monocyte chemoattractant protein 1 mRNA expression, as well as increased acetyl-CoA carboxylase 1 and stearoyl-CoA desaturase-1 protein expression. The HFD altered short-term glucose homeostasis to a greater degree in Keap-KD mice compared to C57BL/6 mice, which was accompanied by downregulation of insulin receptor substrate 1 mRNA expression in skeletal muscle. Together, the results indicate that Keap1 knockdown, on treatment with HFD, increases certain markers of metabolic syndrome.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Free radicals; Keap1; Metabolic syndrome; Nrf2; Steatosis

Mesh:

Substances:

Year:  2013        PMID: 23507082      PMCID: PMC3797262          DOI: 10.1016/j.freeradbiomed.2013.03.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  48 in total

Review 1.  Effects of leptin and adiponectin on pancreatic β-cell function.

Authors:  Yong-ho Lee; Faidon Magkos; Christos S Mantzoros; Eun Seok Kang
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006.

Authors:  R Bethene Ervin
Journal:  Natl Health Stat Report       Date:  2009-05-05

Review 3.  Macrophage polarization in metabolic disorders: functions and regulation.

Authors:  Giulia Chinetti-Gbaguidi; Bart Staels
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

4.  Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology.

Authors:  D P Hartley; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

5.  UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis.

Authors:  Jialin Xu; Supriya R Kulkarni; Liya Li; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2011-10-26       Impact factor: 3.922

6.  Genetic analysis of cytoprotective functions supported by graded expression of Keap1.

Authors:  Keiko Taguchi; Jonathan M Maher; Takafumi Suzuki; Yukie Kawatani; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

Review 7.  Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver.

Authors:  Curtis D Klaassen; Scott A Reisman
Journal:  Toxicol Appl Pharmacol       Date:  2010-02-01       Impact factor: 4.219

8.  Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.

Authors:  Vijay R More; Xia Wen; Paul E Thomas; Lauren M Aleksunes; Angela L Slitt
Journal:  Comp Hepatol       Date:  2012-04-23

9.  Evaluation of 309 environmental chemicals using a mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay.

Authors:  Kelly J Chandler; Marianne Barrier; Susan Jeffay; Harriette P Nichols; Nicole C Kleinstreuer; Amar V Singh; David M Reif; Nisha S Sipes; Richard S Judson; David J Dix; Robert Kavlock; Edward S Hunter; Thomas B Knudsen
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

10.  Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.

Authors:  Hee Yeon Kay; Won Dong Kim; Se Jin Hwang; Hueng-Sik Choi; Richard K Gilroy; Yu-Jui Yvonne Wan; Sang Geon Kim
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

View more
  24 in total

1.  Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis.

Authors:  S C Cazanave; X Wang; H Zhou; M Rahmani; S Grant; D E Durrant; C D Klaassen; M Yamamoto; A J Sanyal
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

Review 2.  Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease.

Authors:  Ning Zhao; Fang-Fang Guo; Ke-Qin Xie; Tao Zeng
Journal:  Cell Mol Life Sci       Date:  2018-06-11       Impact factor: 9.261

3.  Caloric restriction-mediated induction of lipid metabolism gene expression in liver is enhanced by Keap1-knockdown.

Authors:  Supriya R Kulkarni; Laura E Armstrong; Angela L Slitt
Journal:  Pharm Res       Date:  2013-07-25       Impact factor: 4.200

4.  Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice.

Authors:  Jialin Xu; Ajay C Donepudi; Vijay R More; Supriya R Kulkarni; Liya Li; Liangran Guo; Bingfang Yan; Tapan Chatterjee; Neal Weintraub; Angela L Slitt
Journal:  Obesity (Silver Spring)       Date:  2014-11-29       Impact factor: 5.002

5.  Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.

Authors:  Lung-Yi Lee; Ulrike A Köhler; Li Zhang; Drew Roenneburg; Sabine Werner; Jeffrey A Johnson; David P Foley
Journal:  Toxicol Sci       Date:  2014-10-06       Impact factor: 4.849

Review 6.  The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome.

Authors:  Zhiguo Zhang; Shanshan Zhou; Xin Jiang; Yue-Hui Wang; Fengsheng Li; Yong-Gang Wang; Yang Zheng; Lu Cai
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

Review 7.  Modulating NRF2 in Disease: Timing Is Everything.

Authors:  Matthew Dodson; Montserrat Rojo de la Vega; Aram B Cholanians; Cody J Schmidlin; Eli Chapman; Donna D Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-09-26       Impact factor: 13.820

8.  Increased Energy Expenditure, Ucp1 Expression, and Resistance to Diet-induced Obesity in Mice Lacking Nuclear Factor-Erythroid-2-related Transcription Factor-2 (Nrf2).

Authors:  Kevin Schneider; Joshua Valdez; Janice Nguyen; Marquis Vawter; Brandi Galke; Theodore W Kurtz; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2016-02-03       Impact factor: 5.157

Review 9.  Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.

Authors:  Lauren E Tebay; Holly Robertson; Stephen T Durant; Steven R Vitale; Trevor M Penning; Albena T Dinkova-Kostova; John D Hayes
Journal:  Free Radic Biol Med       Date:  2015-06-27       Impact factor: 7.376

10.  Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin.

Authors:  Deanna M Salter; Wei Wei; Pragati P Nahar; Emily Marques; Angela L Slitt
Journal:  Toxicol Sci       Date:  2021-07-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.